Disperazol c/o Biophys Ltd

Disperazol, developed by Copenhagen-based Biophys Ltd, is a novel antifungal agent targeting drug-resistant Candida and other fungal pathogens. It uses a unique mechanism based on disrupting fungal biofilms rather than fungal cell structure , an approach designed to circumvent the resistance pathways that are making existing azole and echinocandin antifungals progressively less effective against serious fungal infections.